Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (r)-9-(2-phosphonylmethoxypropyl)adenine
2. 9-(2-phosphonylmethoxypropyl)adenine
3. 9-(2-phosphonylmethoxypropyl)adenine, (+-)-isomer
4. 9-(2-phosphonylmethoxypropyl)adenine, (r)-isomer - T357098
5. 9-(2-phosphonylmethoxypropyl)adenine, (s)-isomer
6. 9-pmpa (tenofovir)
7. Disoproxil Fumarate, Tenofovir
8. Disoproxil, Tenofovir
9. Fumarate, Tenofovir Disoproxil
10. Tenofovir
11. Tenofovir Disoproxil
12. Tenofovir Disoproxil Fumarate
13. Viread
1. 107021-12-5
2. Tenofovir-d6
3. Apropovir
4. 1-(6-aminopurin-9-yl)propan-2-yloxymethylphosphonic Acid
5. (((1-(6-amino-9h-purin-9-yl)propan-2-yl)oxy)methyl)phosphonic Acid
6. ({[1-(6-amino-9h-purin-9-yl)propan-2-yl]oxy}methyl)phosphonic Acid
7. 1217720-14-3
8. Tenofovir (parent)
9. Mfcd21604708
10. ((2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)phosphonic Acid
11. Mls006011450
12. Schembl497725
13. Chembl315593
14. Dtxsid30861388
15. Bcp02416
16. Vqb71994
17. Bbl032950
18. Stl370337
19. 9-[2-(phosphonomethoxy)propyl]adenine
20. Akos015961830
21. Phosphonic Acid, ((2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)-
22. Smr004703253
23. Sy115900
24. Ft-0601652
25. Ft-0674851
26. Ft-0696939
27. 9-[2-(phosphonomethoxy)propyl]-9h-purin-6-amine
28. A851347
29. (r)-pmpa;gs-1278;gs 1278;gs1278;tdf;pmpa
30. (s)-[[[1-(6-amino-9h-purin-9-yl)-2-propyl]oxy]methyl]phosphonic Acid
Molecular Weight | 287.21 g/mol |
---|---|
Molecular Formula | C9H14N5O4P |
XLogP3 | -1.6 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 5 |
Exact Mass | 287.07834094 g/mol |
Monoisotopic Mass | 287.07834094 g/mol |
Topological Polar Surface Area | 136 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 354 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-HIV Agents
Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)
Reverse Transcriptase Inhibitors
Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?